Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Tani Lee"'
Publikováno v:
Journal of Eurasian Studies, Vol 10 (2019)
This article examines how Russia’s economic crisis and ban on agricultural imports from the United States and other Western countries that began in 2014 have impacted its agricultural and food sector. The import ban was a Russian response to geopol
Externí odkaz:
https://doaj.org/article/79751fcab0e94813a47f534d4d069100
Autor:
Jeeyun Lee, Anjali Jain, Phillip Kim, Tani Lee, Anne Kuller, Fred Princen, In-GuDo, Suk Hyeong Kim, Joon Oh Park, Young Suk Park, Sharat Singh, Hee Cheol Kim
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e103551 (2014)
Oncogenic mutational analysis provides predictive guidance for therapeutics such as anti-EGFR antibodies, but it is successful only for a subset of colorectal cancer (CRC) patients.A comprehensive molecular profiling of 120 CRC patients, including 11
Externí odkaz:
https://doaj.org/article/f76e53c87c2e458995c5d2ce8e10b9a4
Autor:
Jeeyun Lee, Sung Kim, Phillip Kim, Xinjun Liu, Tani Lee, Kyoung-Mee Kim, In-Gu Do, Joon Oh Park, Se Hoon Park, Jiryeon Jang, Nicholas Hoe, Gulia Harvie, Anne Kuller, Anjali Jain, Gary Meyer, Glen Leesman, Young Suk Park, Min Gew Choi, Tae Sung Sohn, Jae Moon Bae, Ho Yeong Lim, Sharat Singh, Won Ki Kang
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54644 (2013)
The aim of this study was to utilize the proteomics-based Collaborative Enzyme Enhanced Reactive (CEER) immunoassay to investigate protein tyrosine phosphorylations as diagnostic markers in gastric cancers (GCs).Protein lysates from fresh-frozen 434
Externí odkaz:
https://doaj.org/article/e271a8bf163e483ea10b893e95bb5eb8
Autor:
C Schneider, Emma Langley, Tani Lee, Thomas Krahn, P. Kim, Sharat Singh, S Hazra, Ahsen O von, Glen Leesman
Publikováno v:
Cancer Research. 71:P3-18
Background: The ability to functionally profile a whole spectrum of pathway proteins in tumor may provide valuable information about the likelihood of drug response and potential mechanisms for drug resistance in breast cancer (BCA) patients. Here we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2eb670f2b131112eeebf9cfa0a1e4e91
https://doi.org/10.1158/0008-5472.sabcs11-p3-18-04
https://doi.org/10.1158/0008-5472.sabcs11-p3-18-04
Autor:
Arndt Schmitz, Christoph A. Schatz, Anne Kuller, Thomas Krahn, Sharat Singh, K. Magonova, Hua C. Gong, Tani Lee, F. Lin, G. Harvie, O. von Ahsen, Robert Barham, Phillip Kim, Glen Leesman
Publikováno v:
Cancer Research. 70:P2-06
Background: Targeted therapeutic strategies are currently limited to patients with hormone receptors and/or HER2 positive disease in breast cancer (BCA) treatment. However, patients often develop resistance to these therapies. The ability to function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c161aff7a9e956a3ba3e3cc395a4c1a
https://doi.org/10.1158/0008-5472.sabcs10-p2-06-13
https://doi.org/10.1158/0008-5472.sabcs10-p2-06-13
Autor:
Se Hoon Park, Jeeyun Lee, Young Suk Park, Jiryeon Jang, In Gu Do, Min Gew Choi, Won Ki Kang, Xinjun Liu, Sharat Singh, Tae Sung Sohn, Jae Moon Bae, Anjali Jain, Tani Lee, Kyoung-Mee Kim, Sung Kim, Glen Leesman, Nicholas Hoe, Phillip Kim, Gary Meyer, Joon Oh Park, Ho Yeong Lim, Anne Kuller, G. Harvie
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 1, p e54644 (2013)
PLOS ONE(8): 1
PLoS ONE, Vol 8, Iss 1, p e54644 (2013)
PLOS ONE(8): 1
Purpose: The aim of this study was to utilize the proteomics-based Collaborative Enzyme Enhanced Reactive (CEER) immunoassay to investigate protein tyrosine phosphorylations as diagnostic markers in gastric cancers (GCs). Experimental Design: Protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cddaa8681d2a27b5fcb323efe2e7e47
http://europepmc.org/articles/PMC3556044
http://europepmc.org/articles/PMC3556044
Autor:
Sharat Singh, Xinjun Liu, Shi Chung Ng, Robert Barham, Tani Lee, Richard Kirkland, Belen Ybarrondo, Anne Kuller, Limin Liu, Glen Leesman, Phillip Kim
Publikováno v:
Proteome Science, Vol 9, Iss 1, p 75 (2011)
Proteome Science
Proteome Science
Background The clinical benefits associated with targeted oncology agents are generally limited to subsets of patients. Even with favorable biomarker profiles, many patients do not respond or acquire resistance. Existing technologies are ineffective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdde6f4711ca56b9caf4514e2385fef8
http://www.proteomesci.com/content/9/1/75
http://www.proteomesci.com/content/9/1/75
Autor:
In-Gu, Suk Hyeong Kim, Anne Kuller, Young Suk Park, Hee Cheol Kim, Anjali Jain, Jeeyun Lee, Sharat Singh, Tani Lee, Phillip Kim, Joon Oh Park, Fred Princen
Publikováno v:
PLOS ONE(9): 8
PLoS ONE, Vol 9, Iss 8, p e103551 (2014)
PLoS ONE
PLoS ONE, Vol 9, Iss 8, p e103551 (2014)
PLoS ONE
Background Oncogenic mutational analysis provides predictive guidance for therapeutics such as anti-EGFR antibodies, but it is successful only for a subset of colorectal cancer (CRC) patients. Method A comprehensive molecular profiling of 120 CRC pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee24c73ad1bb1ad998e463b65961b466
https://doi.org/10.1371/journal.pone.0103551
https://doi.org/10.1371/journal.pone.0103551
Publikováno v:
Cancer Research. 72:3678-3678
Despite overall improvements in colorectal cancer (CRC) therapies, an understanding of reasons for therapeutic response/non-response as well as disease recurrence remains poor. Currently, the gold standard for CRC prognosis remains the clinicopatholo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c79b604333f637c284b725fe23327e04
https://doi.org/10.1158/1538-7445.am2012-3678
https://doi.org/10.1158/1538-7445.am2012-3678
Autor:
Andrew Fithian, Sharat Singh, K. Magonova, Saswati Hazra, Phillip Kim, Edvelyn Webster, Tani Lee, Limin Liu, Robert Barham
Publikováno v:
Cancer Research. 72:1217-1217
Survival rates of metastatic breast cancers (mBCAs) are considerably low. Often, tumor cells at the primary site may not reflect the profile of the tumor cell population in recurrent disease. Circulating tumor cells (CTCs) isolated from peripheral bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea30687738e9059d605473d5cfa3c6fd
https://doi.org/10.1158/1538-7445.am2012-1217
https://doi.org/10.1158/1538-7445.am2012-1217